BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35406637)

  • 1. Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model.
    Albuquerque B; Chen X; Hirenallur-Shanthappa D; Zhao Y; Stansfield JC; Zhang BB; Sheikh A; Wu Z
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the divergent TGFβ superfamily cytokine MIC-1/GDF15 for therapy of anorexia/cachexia syndromes.
    Tsai VW; Brown DA; Breit SN
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):404-409. PubMed ID: 30382947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.
    Tsai VW; Lin S; Brown DA; Salis A; Breit SN
    Int J Obes (Lond); 2016 Feb; 40(2):193-7. PubMed ID: 26620888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation.
    Breen DM; Jagarlapudi S; Patel A; Zou C; Joaquim S; Li X; Kang L; Pang J; Hales K; Ziso-Qejvanaj E; Vera NB; Bennett D; He T; Lambert M; Kelleher K; Wu Z; Zhang BB; Lin L; Seeley RJ; Bezy O
    iScience; 2021 Jun; 24(6):102554. PubMed ID: 34189431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia.
    Kim-Muller JY; Song L; LaCarubba Paulhus B; Pashos E; Li X; Rinaldi A; Joaquim S; Stansfield JC; Zhang J; Robertson A; Pang J; Opsahl A; Boucher M; Breen D; Hales K; Sheikh A; Wu Z; Zhang BB
    Cell Rep; 2023 Jan; 42(1):111947. PubMed ID: 36640326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15.
    Tsai VW; Husaini Y; Manandhar R; Lee-Ng KK; Zhang HP; Harriott K; Jiang L; Lin S; Sainsbury A; Brown DA; Breit SN
    J Cachexia Sarcopenia Muscle; 2012 Dec; 3(4):239-43. PubMed ID: 22936174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice.
    Suriben R; Chen M; Higbee J; Oeffinger J; Ventura R; Li B; Mondal K; Gao Z; Ayupova D; Taskar P; Li D; Starck SR; Chen HH; McEntee M; Katewa SD; Phung V; Wang M; Kekatpure A; Lakshminarasimhan D; White A; Olland A; Haldankar R; Solloway MJ; Hsu JY; Wang Y; Tang J; Lindhout DA; Allan BB
    Nat Med; 2020 Aug; 26(8):1264-1270. PubMed ID: 32661391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice.
    Patel AR; Frikke-Schmidt H; Bezy O; Sabatini PV; Rittig N; Jessen N; Myers MG; Seeley RJ
    Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G247-G255. PubMed ID: 34935522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15.
    Borner T; Arnold M; Ruud J; Breit SN; Langhans W; Lutz TA; Blomqvist A; Riediger T
    J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):417-427. PubMed ID: 28025863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15.
    Jones JE; Cadena SM; Gong C; Wang X; Chen Z; Wang SX; Vickers C; Chen H; Lach-Trifilieff E; Hadcock JR; Glass DJ
    Cell Rep; 2018 Feb; 22(6):1522-1530. PubMed ID: 29425507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss.
    Borner T; Wald HS; Ghidewon MY; Zhang B; Wu Z; De Jonghe BC; Breen D; Grill HJ
    Cell Rep; 2020 Apr; 31(3):107543. PubMed ID: 32320650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP3K11/GDF15 axis is a critical driver of cancer cachexia.
    Lerner L; Tao J; Liu Q; Nicoletti R; Feng B; Krieger B; Mazsa E; Siddiquee Z; Wang R; Huang L; Shen L; Lin J; Vigano A; Chiu MI; Weng Z; Winston W; Weiler S; Gyuris J
    J Cachexia Sarcopenia Muscle; 2016 Sep; 7(4):467-82. PubMed ID: 27239403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice.
    Lee BY; Jeong J; Jung I; Cho H; Jung D; Shin J; Park JK; Park E; Noh S; Shin S; Kang S; Heo JI; Baek MC; Yea K
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1441-1453. PubMed ID: 37017344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
    Steffen BT; Lees SJ; Booth FW
    J Appl Physiol (1985); 2008 Dec; 105(6):1950-8. PubMed ID: 18801959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDF15 Induces Anorexia through Nausea and Emesis.
    Borner T; Shaulson ED; Ghidewon MY; Barnett AB; Horn CC; Doyle RP; Grill HJ; Hayes MR; De Jonghe BC
    Cell Metab; 2020 Feb; 31(2):351-362.e5. PubMed ID: 31928886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of growth differentiation factor 15 in cancer cachexia (Review).
    Ling T; Zhang J; Ding F; Ma L
    Oncol Lett; 2023 Nov; 26(5):462. PubMed ID: 37780545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
    Qin T; Kong B; Dai C; Xiao Z; Fang J; Shuai W; Huang H
    Bioengineered; 2022 Feb; 13(2):2697-2709. PubMed ID: 35042435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.
    Ghidewon M; Wald HS; McKnight AD; De Jonghe BC; Breen DM; Alhadeff AL; Borner T; Grill HJ
    Diabetes Obes Metab; 2022 Jun; 24(6):1010-1020. PubMed ID: 35129264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond.
    Mullican SE; Rangwala SM
    Trends Endocrinol Metab; 2018 Aug; 29(8):560-570. PubMed ID: 29866502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDF15: A Hormone Conveying Somatic Distress to the Brain.
    Lockhart SM; Saudek V; O'Rahilly S
    Endocr Rev; 2020 Aug; 41(4):. PubMed ID: 32310257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.